SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
|
|
|
StemCells, Inc. Provides Update on NCL Program Meeting with FDA
StemCells, Inc. (NASDAQ: STEM) today provided an update on the ongoing clinical development program of its proprietary HuCNS-SC® product candidate (purified human neural stem cells) for neuronal ceroid lipofuscinosis (NCL),...
... more »
|
|
|
|
|
PMD Clinical Trial
In the winter of 2009/10, UCSF Children's Hospital will begin a Phase I safety study sponsored by StemCells, Inc. for a potential new therapy for connatal Pelizaeus-Merzbacher Disease (PMD), which is a rare inherited condition involving the central nervous system. Children with PM...
... more »
|
|
|
|
|
I think the significance of this Press Release has been overlooked, and hope the company has more plans to explain its story:
Emergent Health Corp. (EMGE) Announces Patent Approval For Adult Stem
Cell Product
King of Prussia, PA--March 09, 2009 (GLOBE NEWSWIRE) --Emergent Health Corp. (OTC:EMG...
... more »
|
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on STEM |
Visit streetinsider.com
More Resources
|
About StemCells Inc.
- Answers.com
